澳门太阳游戏城app官网入口

目录产品 » TRAIL R4/TNFRSF10D, His & Avi, Human

TRAIL R4/TNFRSF10D, His & Avi, Human

TNF-related apoptosis inducing ligand (TRAIL) is a potential antitumor protein known for its ability to selectively eliminate various types of tumor cells without exerting toxic effects in normal cells and tissues. TRAIL-R2/DR5 as well as TRAIL-R3/DcR1 and TRAIL-R4/DcR2 were significantly higher expressed in advanced tumour stages.
¥3500
Z05914-100

Species Human
Protein Construction
TRAIL R4/TNFRSF10D (Ala56-His211)_x000D_
Accession # Q9UBN6
His Avi
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 19.4 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 38-45 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.
返回

TRAIL R4/TNFRSF10D, His & Avi, Human

Immobilized Human Trail, No Tag at 5 μg/ml (100 μl/well) on the plate. Dose response curve for TRAIL R4/TNFRSF10D, His & Avi, Human, His Tag with the EC50 of 0.13 μg/ml determined by ELISA. »

TRAIL R4/TNFRSF10D, His & Avi, Human

The purity of TRAIL R4/TNFRSF10D, His & Avi, Human is greater than 95% as determined by SEC-HPLC. »

TRAIL R4/TNFRSF10D, His & Avi, Human

TRAIL R4/TNFRSF10D, His & Avi, Human on Bis-Tris PAGE under reduced conditions. The purity is greater than 95%. »

TRAIL R4/TNFRSF10D, His & Avi, Human

TRAIL R4/TNFRSF10D, His & Avi, Human, His Tag immobilized on CM5 Chip can bind Human TRAIL, No Tag with an affinity constant of 0.13 nM as determined in SPR assay (Biacore T200). »

<
>

Target Background TNF-related apoptosis inducing ligand (TRAIL) is a potential antitumor protein known for its ability to selectively eliminate various types of tumor cells without exerting toxic effects in normal cells and tissues. TRAIL-R2/DR5 as well as TRAIL-R3/DcR1 and TRAIL-R4/DcR2 were significantly higher expressed in advanced tumour stages.
Synonyms CD264; RSF10D; TRAILR4; DCR2; TRUNDD; TNFRSF10D
返回

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.